HopeStage
Back to all studies
CompletedNCT01067846

D-cycloserine or placebo with cognitive behavioral therapy for cocaine addiction

About this titleRead the official source — NCT01067846
Medication studyAges 18–65United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
Little RockSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJune 2010
Recruitment status
Completed
Enrollment listed in the registry
85
Sponsor
University of Arkansas
Sponsor type
University
Study type
Behavioral
Intervention type
Behavioural, Drug
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT01067846
Official title
Show the full official title

The Clinical and Neural Response of Cocaine Addicts to Combination Treatment With a Cognitive Enhancer and Extinction-Based Psychotherapy

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Little Rock

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Arkansas, a university.

Did this study involve medication?

Yes. The study involved medication, including Seromycin (D-cycloserine, DCS) and Placebo.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies